Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects. 2022

Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

Lipid metabolism disorders contribute to the risk factor of prostatic hyperplasia. Lipid ratios have also attracted a lot of attention. Yet, research about the correlation of lipid ratios with prostatic hyperplasia is limited. Hence, the aim of this study was to investigate the association of lipid ratios with the risk of benign prostatic hyperplasia (BPH) in Chinese male subjects. Healthy men who underwent routine health check-ups from January 2017 to December 2019 were recruited. Twenty-four thousand nine hundred sixty-two individuals were finally enrolled in this research. Binary logistic regression analysis was performed to investigate the relationship between lipid ratios and BPH in Chinese adults. After health examinations for more than 2 years, 18.46% of subjects were ascertained as incident BPH cases. Higher age, body mass index (BMI), prostate-specific antigen (PSA), triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) ratio, and lower high-density lipoprotein cholesterol (HDL-C) were significantly associated with BPH risk, while total cholesterol (TC) was not significant. When quartiles of TG/HDL-C and TC/HDL-C were analyzed in multivariable model, higher TG/HDL-C and TC/HDL-C were associated with a risk of BPH (odds ratio [OR] = 2.11; 95% confidence interval [CI]: 1.89, 2.36; P-trend < 0.001; and OR = 1.67; 95% CI: 1.50, 1.85; P-trend < 0.001, respectively). In addition, stratified analyses based on the general population exhibited that with increasing age (≥35 years) the relationship of TG/HDL-C ratio with BPH risk was dominantly positive (all P-trend < 0.001, P-interaction = 0.001), and significant associations were also found in blood pressure strata and FBG strata (all P-trend < 0.001), except men with BMI ≥ 28 kg/m2 were slightly weakened (OR = 2.01, 95% CI: 1.41, 2.85; P-trend = 0.04). Moreover, there were significant associations between quartiles of TC/HDL-C and the risk of BPH was observed mainly in age 55-64 years, BMI 18.5-23.9 Kg/m2, blood pressure strata, and FBG strata. However, the P-value for a linear trend among those with BMI ≥ 28 Kg/m2 in which participants at the highest quartile of TC/HDL-C had an OR of 1.45 (95% CI: 1.09, 1.93) was 0.594. Additionally, higher TG/HDL-C ratio (≥0.65) may be a risk factor for BPH in China adults of different age decades (≥35 years) with normal TG and HDL-C. TG/HDL-C and TC/HDL-C were associated with BPH risk, TG/HDL-C was a powerful independent risk factor for BPH in Chinese adults, and higher TG/HDL-C ratio should be valued in male subjects with normal TG and HDL-C levels.

UI MeSH Term Description Entries

Related Publications

Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
September 2006, Metabolism: clinical and experimental,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
March 2019, Annals of pediatric endocrinology & metabolism,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
May 2014, VASA. Zeitschrift fur Gefasskrankheiten,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
September 2020, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
February 2019, The Journal of urology,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
May 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
September 2017, The aging male : the official journal of the International Society for the Study of the Aging Male,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
November 2020, Internal medicine (Tokyo, Japan),
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
October 2014, Journal of the American Society of Hypertension : JASH,
Chen Zhu, and Juan Wu, and Yixian Wu, and Wen Guo, and Jing Lu, and Wenfang Zhu, and Xiaona Li, and Nianzhen Xu, and Qun Zhang
March 2023, Scientific reports,
Copied contents to your clipboard!